FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during

Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California

FILE PHOTO: Gilead Sciences is seen in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Copyright © 2024 Active Trader Daily - Succinct Financial News.
Copyright © 2024 Active Trader Daily - Succinct Financial News.